There are several studies that have indicated the significant roles of hnRNP‐K in the development and progression of several cancers, including cancers of the bladder (Chen et al., 2017), breast (Dhanjal et al., 2014), colon (Zhang et al., 2016b), pancreas (Zhou et al., 2010), prostate (Barboro et al., 2014b), lung (Li et al., 2011), cervix (Zhang et al., 2016a), and liver (Xiao et al., 2013). Here, HNRNPK is linked to cancer.